These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17598934)

  • 1. Subclinical inflammation, C-reactive protein & cardiovascular risk.
    Heald AH
    Indian J Med Res; 2007 Apr; 125(4):502-4. PubMed ID: 17598934
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy and clinical trials.
    Duttaroy AK
    Curr Opin Lipidol; 2006 Aug; 17(4):492-4. PubMed ID: 16832176
    [No Abstract]   [Full Text] [Related]  

  • 3. Hot and bothered: C-reactive protein, inflammation and atherosclerosis.
    Wierzbicki AS
    Int J Clin Pract; 2009 Nov; 63(11):1550-3. PubMed ID: 19832810
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease. Does inflammation cut to the heart of the matter?
    Taubes G
    Science; 2002 Apr; 296(5566):242-5. PubMed ID: 11951014
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation.
    Lavie CJ; Church TS; Milani RV; Earnest CP
    J Cardiopulm Rehabil Prev; 2011; 31(3):137-45. PubMed ID: 21427600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of C-reactive protein in asthma].
    Kociniak T; Skiepko R; Zietkowski Z; Bodzenta-Łukaszyk A
    Przegl Lek; 2010; 67(7):472-4. PubMed ID: 21387758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What else does the JUPITER trial add regarding C-reactive protein and cardiovascular disease?
    Lin GM; Li YH; Chu KM; Han CL
    Int J Cardiol; 2011 Jun; 149(3):387. PubMed ID: 21450359
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.
    May A; Wang TJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical risk markers: a novel area for better prediction of renal risk?
    Stuveling EM; Bakker SJ; Hillege HL; de Jong PE; Gans RO; de Zeeuw D
    Nephrol Dial Transplant; 2005 Mar; 20(3):497-508. PubMed ID: 15735241
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac biomarkers: myths, facts and future horizons.
    Dotsenko O; Chackathayil J; Lip GY
    Expert Rev Mol Diagn; 2007 Nov; 7(6):693-7. PubMed ID: 18020898
    [No Abstract]   [Full Text] [Related]  

  • 11. Does tissue factor expression by vascular smooth muscle cells provide a link between C-reactive protein and cardiovascular disease?
    Mackman N; Taubman MB
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):601-3. PubMed ID: 18354090
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prognostic value of C-reactive protein in ischemic cardiopathy].
    Bazzino O; Natale E
    Medicina (B Aires); 2001; 61(2):239-42. PubMed ID: 11374151
    [No Abstract]   [Full Text] [Related]  

  • 13. High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus.
    Nikpour M; Harvey PJ; Ibanez D; Gladman DD; Urowitz MB
    Arthritis Rheum; 2012 Sep; 64(9):3052-3. PubMed ID: 22614710
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of whole grains on markers of subclinical inflammation.
    Lefevre M; Jonnalagadda S
    Nutr Rev; 2012 Jul; 70(7):387-96. PubMed ID: 22747841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity C-reactive protein: clinical importance.
    Bassuk SS; Rifai N; Ridker PM
    Curr Probl Cardiol; 2004 Aug; 29(8):439-93. PubMed ID: 15258556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biomedical risk markers for cardiovascular disease.
    Magliano DJ; Liew D; Ashton EL; Sundararajan V; McNeil JJ
    J Cardiovasc Risk; 2003 Feb; 10(1):41-55. PubMed ID: 12569236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioactive isoprostanes. New markers of oxidative stress and inflammation-related diseases].
    Basu S; Helmersson J
    Lakartidningen; 2009 Jan 28-Feb 3; 106(5):274-8. PubMed ID: 19271455
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein and cardiovascular risk in the Framingham Study.
    Ridker P; Rifai N; Koenig W; Blumenthal RS
    Arch Intern Med; 2006 Jun; 166(12):1327-8; author reply 1328. PubMed ID: 16801524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.